233 related articles for article (PubMed ID: 34706493)
1. Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure.
Javier J; Hinge A; Bartram J; Xu J; Filippi MD
Haematologica; 2022 Jun; 107(6):1323-1334. PubMed ID: 34706493
[TBL] [Abstract][Full Text] [Related]
2. Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes.
Risitano AM; Maciejewski JP; Selleri C; Rotoli B
Curr Stem Cell Res Ther; 2007 Jan; 2(1):39-52. PubMed ID: 18220891
[TBL] [Abstract][Full Text] [Related]
3. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
4. The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?
Wang J; Erlacher M; Fernandez-Orth J
Front Immunol; 2022; 13():951937. PubMed ID: 36032161
[TBL] [Abstract][Full Text] [Related]
5. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Thomas ME; Abdelhamed S; Hiltenbrand R; Schwartz JR; Sakurada SM; Walsh M; Song G; Ma J; Pruett-Miller SM; Klco JM
Leukemia; 2021 Nov; 35(11):3232-3244. PubMed ID: 33731850
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
7. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
9. Immune-induced cytopenia: bone marrow failure syndrome.
Kondo Y; Molldrem JJ
Curr Hematol Rep; 2004 May; 3(3):178-83. PubMed ID: 15087065
[TBL] [Abstract][Full Text] [Related]
10. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
11. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
[TBL] [Abstract][Full Text] [Related]
12. Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.
Solimando AG; Palumbo C; Pragnell MV; Bittrich M; Argentiero A; Krebs M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233062
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and prognostic factors in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Leuk Lymphoma; 2002 Feb; 43(2):257-60. PubMed ID: 11999555
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes.
Aoyagi Y; Hayashi Y; Harada Y; Choi K; Matsunuma N; Sadato D; Maemoto Y; Ito A; Yanagi S; Starczynowski DT; Harada H
Cancer Discov; 2022 Jan; 12(1):250-269. PubMed ID: 34462274
[TBL] [Abstract][Full Text] [Related]
16. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
17. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.
Wei Y; Zheng H; Bao N; Jiang S; Bueso-Ramos CE; Khoury J; Class C; Lu Y; Lin K; Yang H; Ganan-Gomez I; Starczynowski DT; Do KA; Colla S; Garcia-Manero G
Blood Adv; 2018 Oct; 2(19):2491-2504. PubMed ID: 30275007
[TBL] [Abstract][Full Text] [Related]
18. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
[TBL] [Abstract][Full Text] [Related]
19. Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.
Matos A; Magalhães SMM; Rauh MJ
Adv Exp Med Biol; 2021; 1326():1-10. PubMed ID: 33385175
[TBL] [Abstract][Full Text] [Related]
20. The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment.
Daw S; Law S
Mol Cell Biochem; 2021 Feb; 476(2):535-551. PubMed ID: 33011884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]